Orthokeratology, 0.04% Atropine, and 0.01% Atropine for Myopia Control: A Randomized Clinical Trial.

已完结 20 由 11 发布于 2025/11/13 22:14:55

DOI:10.1001/jamaophthalmol.2025.2321
作者：Hannan Xu,Moxin Chen,Luyao Ye,Qin Shu,Yajun Peng,Xiaoyi Liang,Tao Yu,Yongrong Ji,Shanshan Li,Qin Shen,Jiangnan He,Lin Li,Jianfeng Zhu,Xun Xu
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1001/jamaophthalmol.2025.2321

JAMA

Abstract：Importance Investigating the antimyopia efficacy and safety of orthokeratology and varying atropine doses in specific age groups could optimize personalized treatment choices. Objective

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierA collaborative reflection on the synergy of Artificial Intelligence (AI) and language teacher identity reconstruction